TRAC and cancer: For example, CRISPR has been employed to insert CAR in the T-cell receptor alpha constant (TRAC) locus and to delete several genes, including PD-1, to improve antitumor effect in various cancer models (Choi et al., 2019; Stadtmauer et al., 2020a).